0 results for 'Valeant Pharmaceuticals International Inc'
Baker & McKenzie, Clayton Utz Lead on Canadian-Aussie Pharma Deal
The two firms are advising on a $691 million deal under which Canada's Valeant Pharmaceutical International, Inc. will buy Sydney-based iNova Pharmaceuticals. Baker & McKenzie and Clayton Utz are acting for the buyer and target, respectively.Seven Am Law 100 Firms Land Roles on Pair of Drug Deals
German pharmaceutical giant Bayer said Monday it has agreed to acquire contraceptive device company Conceptus for $1.1 billion, while Auxilium Pharmaceuticals announced its $585 million purchase of urology-focused drug company Actient Holdings. Sullivan & Cromwell has roles on both deals, which also generated assignments for Hogan Lovells, Jones Day, Kirkland, Latham, Morgan Lewis, and Willkie.
Bausch & Lomb agrees to buy Ista Pharma for $500M
Eye-health company Bausch & Lomb plans to buy eye-drug maker Ista Pharmaceuticals Inc. for $9.10 per share, or about $500 million in cash, the companies said Monday.Leading M&A Transactions — Target or Acquirer Based in N.J. — 2011
TRENDING STORIES
More from ALM
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
Resources
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now
A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster
Brought to you by HaystackID
Download Now
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now